Literature DB >> 34228779

IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19: Who, When, and How?

Michael A Matthay1, Anne F Luetkemeyer2.   

Abstract

Entities:  

Year:  2021        PMID： 34228779     DOI： 10.1001/jama.2021.11121

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

Review 1.  Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases.

Authors:  Ying-Shuang Li; Hua-Cheng Ren; Jian-Hua Cao
Journal:  Int Immunopharmacol       Date:  2022-06-28       Impact factor: 5.714

Review 2.  Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19.

Authors:  Jonathan D Casey; Laura M Beskow; Jeremy Brown; Samuel M Brown; Étienne Gayat; Michelle Ng Gong; Michael O Harhay; Samir Jaber; Jacob C Jentzer; Pierre-François Laterre; John C Marshall; Michael A Matthay; Todd W Rice; Yves Rosenberg; Alison E Turnbull; Lorraine B Ware; Wesley H Self; Alexandre Mebazaa; Sean P Collins
Journal:  Lancet Respir Med       Date:  2022-06-13       Impact factor: 102.642

Review 3.  Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19.

Authors:  Ivo Udovicic; Ivan Stanojevic; Dragan Djordjevic; Snjezana Zeba; Goran Rondovic; Tanja Abazovic; Srdjan Lazic; Danilo Vojvodic; Kendrick To; Dzihan Abazovic; Wasim Khan; Maja Surbatovic
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

4.  The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis.

Authors:  Xueyang Zhang; Lianhan Shang; Guohui Fan; Xiaoying Gu; Jiuyang Xu; Yeming Wang; Lixue Huang; Bin Cao
Journal:  Front Med (Lausanne)       Date:  2022-01-27

Review 5.  Alamandine: Potential Protective Effects in SARS-CoV-2 Patients.

Authors:  Ava Soltani Hekmat; Kazem Javanmardi
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-11-08       Impact factor: 1.636

6.  Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial.

Authors:  Jozefien Declercq; Karel F A Van Damme; Elisabeth De Leeuw; Bastiaan Maes; Cedric Bosteels; Simon J Tavernier; Stefanie De Buyser; Roos Colman; Maya Hites; Gil Verschelden; Tom Fivez; Filip Moerman; Ingel K Demedts; Nicolas Dauby; Nicolas De Schryver; Elke Govaerts; Stefaan J Vandecasteele; Johan Van Laethem; Sebastien Anguille; Jeroen van der Hilst; Benoit Misset; Hans Slabbynck; Xavier Wittebole; Fabienne Liénart; Catherine Legrand; Marc Buyse; Dieter Stevens; Fre Bauters; Leen J M Seys; Helena Aegerter; Ursula Smole; Victor Bosteels; Levi Hoste; Leslie Naesens; Filomeen Haerynck; Linos Vandekerckhove; Pieter Depuydt; Eva van Braeckel; Sylvie Rottey; Isabelle Peene; Catherine Van Der Straeten; Frank Hulstaert; Bart N Lambrecht
Journal:  Lancet Respir Med       Date:  2021-10-29       Impact factor: 30.700

Review 7.  Ofeleein i mi Vlaptin-Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic.

Authors:  Jannis Kountouras; Dimitra Gialamprinou; Georgios Kotronis; Apostolis Papaefthymiou; Eleftheria Economidou; Elpidoforos S Soteriades; Elisabeth Vardaka; Dimitrios Chatzopoulos; Maria Tzitiridou-Chatzopoulou; Dimitrios David Papazoglou; Michael Doulberis
Journal:  Medicina (Kaunas)       Date:  2022-02-17       Impact factor: 2.430

8.  Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial.

Authors:  Sepideh Barzin Tond; Laurent Balenci; Nasim Khajavirad; Mohammadreza Salehi; Abbas Tafakhori; Mohammad Reza Shahmohammadi; Fereshteh Ghiasvand; Sirous Jafari; Sara Abolghasemi; Farzad Mokhtari; Somayyeh Mahmoodi Baram; Tayebe Zarei; Davood Kazemi; Esmaeil Mohammadnejad; Akram Shah-Hosseini; Alireza Haghbin Toutounchi; Soudabeh Fallah; Ali Riazi; Saeed Karima
Journal:  Inflammopharmacology       Date:  2022-02-24       Impact factor: 5.093

9.  The Impact of Tocilizumab on Radiological Changes Assessed by Quantitative Chest CT in Severe COVID-19 Patients.

Authors:  Ana-Maria-Jennifer Anghel; Cristian-Mihail Niculae; Eliza-Daniela Manea; Mihai Lazar; Mara Popescu; Anca-Cristina Damalan; Adela-Abigaela Bel; Iulia-Maria Nedelcu; Raluca-Elena Patrascu; Adriana Hristea
Journal:  J Clin Med       Date:  2022-02-25       Impact factor: 4.241

Review 10.  Promises and challenges of personalized medicine to guide ARDS therapy.

Authors:  Katherine D Wick; Daniel F McAuley; Joseph E Levitt; Jeremy R Beitler; Djillali Annane; Elisabeth D Riviello; Carolyn S Calfee; Michael A Matthay
Journal:  Crit Care       Date:  2021-11-23       Impact factor: 19.334
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.